Skip to main content

TriSalus Life Sciences, Inc. (TLSI) Stock Forecast 2025 - AI Price Prediction & Analysis


TriSalus Life Sciences, Inc. (TLSI) AI Stock Price Forecast & Investment Analysis

TriSalus Life Sciences, Inc. Stock Price Chart and Technical Analysis

Loading TriSalus Life Sciences, Inc. interactive price chart and technical analysis...

TriSalus Life Sciences, Inc. (TLSI) - Comprehensive Stock Analysis & Investment Research

Deep dive into TriSalus Life Sciences, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about TriSalus Life Sciences, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For TriSalus Life Sciences, Inc.: TriSalus Life Sciences, Inc. operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

TriSalus Life Sciences, Inc. (Stock Symbol: TLSI) is a leading company in the Industrial Applications and Services sector , specifically operating within the Surgical & Medical Instruments & Apparatus industry.

.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing TriSalus Life Sciences, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For TriSalus Life Sciences, Inc.:

Market Capitalization: $187 million - Classified as a small-cap investment offering high growth potential.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for TriSalus Life Sciences, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For TriSalus Life Sciences, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for TriSalus Life Sciences, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: TriSalus Life Sciences, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For TriSalus Life Sciences, Inc.: Market positioning analysis based on available financial and operational metrics.

TriSalus Life Sciences, Inc. strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

TriSalus Life Sciences, Inc. (TLSI) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for TriSalus Life Sciences, Inc. stock analysis.

Loading TriSalus Life Sciences, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into TriSalus Life Sciences, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if TriSalus Life Sciences, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For TriSalus Life Sciences, Inc.: With a P/E ratio of -3.63, the market sees the stock as potentially undervalued.

P/E Ratio -3.63x
P/B Ratio -5.55x
Market Cap $187M
EPS $-1.06
Book Value/Share $-1.06
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently TriSalus Life Sciences, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For TriSalus Life Sciences, Inc.:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess TriSalus Life Sciences, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For TriSalus Life Sciences, Inc.:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal TriSalus Life Sciences, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For TriSalus Life Sciences, Inc.:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively TriSalus Life Sciences, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For TriSalus Life Sciences, Inc.:

Understanding Financial Statement Data

What these metrics mean: Key figures from TriSalus Life Sciences, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For TriSalus Life Sciences, Inc.:

Income Statement ($ Millions)
Operating Income $-1M
R&D Expense $24M
Cost of Goods Sold $3M
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Shares Outstanding 38M
Growth Metrics (YoY)
EPS Growth -27.5%

Latest TriSalus Life Sciences, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting TriSalus Life Sciences, Inc. (TLSI) stock price and investment outlook.

TriSalus Life Sciences, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of TriSalus Life Sciences, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADGM Unlock Forecast - 30 Days FREE Trial $21M x 2.4x
ALUR Unlock Forecast - 30 Days FREE Trial $15M -0.4x -0.3x
ANGO Unlock Forecast - 30 Days FREE Trial $510M -1.4x 2.9x
ANIK Unlock Forecast - 30 Days FREE Trial $144M -4.3x 1.0x
AORT Unlock Forecast - 30 Days FREE Trial $1991M -198.2x 4.7x
APYX Unlock Forecast - 30 Days FREE Trial $116M -3.5x 16.1x
ARAY Unlock Forecast - 30 Days FREE Trial $177M -9.9x 2.2x
ATEC Unlock Forecast - 30 Days FREE Trial $2468M -7.4x 103.8x
ATRC Unlock Forecast - 30 Days FREE Trial $1812M -39.6x 3.9x
AVHHL Unlock Forecast - 30 Days FREE Trial $30M x x
BAX Unlock Forecast - 30 Days FREE Trial $11750M -94.9x 1.6x
BBNX Unlock Forecast - 30 Days FREE Trial $1069M x 3.5x
BDX Unlock Forecast - 30 Days FREE Trial $53180M 34.1x 2.1x
BEAT Unlock Forecast - 30 Days FREE Trial $58M -5.7x 13.9x
BJDX Unlock Forecast - 30 Days FREE Trial $4M -0.5x 0.7x
BSX Unlock Forecast - 30 Days FREE Trial $150779M 61.0x 6.7x
BVS Unlock Forecast - 30 Days FREE Trial $477M -18.3x 3.0x
CARL Unlock Forecast - 30 Days FREE Trial $60M x x
CERS Unlock Forecast - 30 Days FREE Trial $284M -13.8x 5.1x
CLPT Unlock Forecast - 30 Days FREE Trial $718M -23.5x 36.4x
CODX Unlock Forecast - 30 Days FREE Trial $12M -0.7x 0.3x
CVRX Unlock Forecast - 30 Days FREE Trial $280M -5.5x 4.8x
DCTH Unlock Forecast - 30 Days FREE Trial $355M 160.2x 3.4x
DRTS Unlock Forecast - 30 Days FREE Trial $362M x 4.2x
DXCM Unlock Forecast - 30 Days FREE Trial $27152M 49.1x 10.6x
EBRCZ Unlock Forecast - 30 Days FREE Trial $427M x 8.6x
EMBC Unlock Forecast - 30 Days FREE Trial $822M 15.8x -0.8x
FEMY Unlock Forecast - 30 Days FREE Trial $23M -1.4x 15.2x
FOFA Unlock Forecast - 30 Days FREE Trial $7M x 12.7x
GIPL Unlock Forecast - 30 Days FREE Trial $7M x 36.1x
GKOS Unlock Forecast - 30 Days FREE Trial $4453M -46.3x 5.8x
GMED Unlock Forecast - 30 Days FREE Trial $8668M 24.1x 2.0x
GUTS Unlock Forecast - 30 Days FREE Trial $69M x 13.8x
HAE Unlock Forecast - 30 Days FREE Trial $2466M 26.1x 2.8x
HRGN Unlock Forecast - 30 Days FREE Trial $29M x 38.2x
IART Unlock Forecast - 30 Days FREE Trial $1198M 200.2x 1.2x
ICCM Unlock Forecast - 30 Days FREE Trial $48M x 16.6x
ICUI Unlock Forecast - 30 Days FREE Trial $3034M -49.8x 1.4x
IDXG Unlock Forecast - 30 Days FREE Trial $4M 0.8x -0.9x
IINN Unlock Forecast - 30 Days FREE Trial $27M x 6.2x
IINNW Unlock Forecast - 30 Days FREE Trial $10M x 2.4x
INBS Unlock Forecast - 30 Days FREE Trial $8M -0.3x 2.7x
INFU Unlock Forecast - 30 Days FREE Trial $207M 40.8x 3.8x
INSP Unlock Forecast - 30 Days FREE Trial $2312M 43.2x 3.4x
IRMD Unlock Forecast - 30 Days FREE Trial $987M 48.3x 10.5x
IRTC Unlock Forecast - 30 Days FREE Trial $5865M -20.2x 56.6x
KIDS Unlock Forecast - 30 Days FREE Trial $390M -20.7x 1.1x
KMTS Unlock Forecast - 30 Days FREE Trial $1438M x x
KRMD Unlock Forecast - 30 Days FREE Trial $196M -19.8x 11.9x
LMAT Unlock Forecast - 30 Days FREE Trial $2063M 43.4x 5.7x
LNSR Unlock Forecast - 30 Days FREE Trial $143M -6.7x -7.0x
LUCD Unlock Forecast - 30 Days FREE Trial $130M -0.6x 16.6x
LUNG Unlock Forecast - 30 Days FREE Trial $62M -4.3x 0.9x
MCAG Unlock Forecast - 30 Days FREE Trial $33M x -9.6x
MCAGU Unlock Forecast - 30 Days FREE Trial $31M x -9.9x
MDNC Unlock Forecast - 30 Days FREE Trial $59M 26.2x 12.2x
MDXG Unlock Forecast - 30 Days FREE Trial $997M 30.5x 4.6x
MGRM Unlock Forecast - 30 Days FREE Trial $217M -10.7x 25.1x
MHUA Unlock Forecast - 30 Days FREE Trial $11M x 0.1x
MMM Unlock Forecast - 30 Days FREE Trial $88624M 26.8x 19.2x
MMSI Unlock Forecast - 30 Days FREE Trial $4903M 41.1x 3.3x
NEPH Unlock Forecast - 30 Days FREE Trial $52M 39.1x 6.2x
NMTC Unlock Forecast - 30 Days FREE Trial $41M -1.7x 5.0x
NPCE Unlock Forecast - 30 Days FREE Trial $351M -10.4x 18.1x
NSPR Unlock Forecast - 30 Days FREE Trial $74M -4.3x 3.6x
NVCR Unlock Forecast - 30 Days FREE Trial $1519M -20.8x 4.4x
NXGL Unlock Forecast - 30 Days FREE Trial $20M -6.8x 4.3x
OBIO Unlock Forecast - 30 Days FREE Trial $153M -3.4x 1.5x
OFIX Unlock Forecast - 30 Days FREE Trial $636M -5.8x 1.4x
OSRH Unlock Forecast - 30 Days FREE Trial $11M x 0.1x
OSUR Unlock Forecast - 30 Days FREE Trial $223M 17.1x 0.6x
PAVM Unlock Forecast - 30 Days FREE Trial $10M 0.1x 0.3x
PDEX Unlock Forecast - 30 Days FREE Trial $93M 10.3x 2.5x
PEN Unlock Forecast - 30 Days FREE Trial $9235M 67.4x 7.1x
PLRZ Unlock Forecast - 30 Days FREE Trial $6M x 0.3x
PLSE Unlock Forecast - 30 Days FREE Trial $1183M -2.6x 11.3x
PMI Unlock Forecast - 30 Days FREE Trial $37M x x
PODD Unlock Forecast - 30 Days FREE Trial $22912M 97.8x 15.7x
PRCT Unlock Forecast - 30 Days FREE Trial $2020M -45.4x 5.2x
PROF Unlock Forecast - 30 Days FREE Trial $165M x 4.2x
PSTV Unlock Forecast - 30 Days FREE Trial $57M -0.3x 18.8x
PYPD Unlock Forecast - 30 Days FREE Trial $51M x 2.5x
RCEL Unlock Forecast - 30 Days FREE Trial $106M -5.0x -29.9x
RDGL Unlock Forecast - 30 Days FREE Trial $35M x 13.0x
RMD Unlock Forecast - 30 Days FREE Trial $37558M 27.7x 6.3x
RSMDF Unlock Forecast - 30 Days FREE Trial $3625M 2.6x 0.6x
RTGN Unlock Forecast - 30 Days FREE Trial $66M x x
RVP Unlock Forecast - 30 Days FREE Trial $27M -0.9x 0.4x
SGHT Unlock Forecast - 30 Days FREE Trial $275M -3.7x 3.9x
SIBN Unlock Forecast - 30 Days FREE Trial $676M -14.3x 4.0x
SKIN Unlock Forecast - 30 Days FREE Trial $185M -1.8x 2.5x
SNOA Unlock Forecast - 30 Days FREE Trial $6M -5.6x 1.6x
SNWV Unlock Forecast - 30 Days FREE Trial $266M x -19.4x
SOLV Unlock Forecast - 30 Days FREE Trial $12297M 32.9x 3.4x
SRTS Unlock Forecast - 30 Days FREE Trial $53M 31.6x 1.0x
SSKN Unlock Forecast - 30 Days FREE Trial $8M -8.0x 25.6x
STIM Unlock Forecast - 30 Days FREE Trial $206M -1.0x 7.6x
STME Unlock Forecast - 30 Days FREE Trial $20M x x
STSS Unlock Forecast - 30 Days FREE Trial $5M -2.5x 0.3x
SYK Unlock Forecast - 30 Days FREE Trial $145259M 50.7x 12.4x
TCMD Unlock Forecast - 30 Days FREE Trial $342M 22.3x 1.8x
TELA Unlock Forecast - 30 Days FREE Trial $61M -1.8x 6.6x
TFX Unlock Forecast - 30 Days FREE Trial $5892M 31.0x 1.4x
TLSI Unlock Forecast - 30 Days FREE Trial $187M -3.6x -5.6x
TMCI Unlock Forecast - 30 Days FREE Trial $430M -7.5x 4.4x
TNDM Unlock Forecast - 30 Days FREE Trial $1031M -17.1x 7.7x
TNON Unlock Forecast - 30 Days FREE Trial $9M -0.3x 1.4x
UFPT Unlock Forecast - 30 Days FREE Trial $1557M 44.7x 4.0x
USAQ Unlock Forecast - 30 Days FREE Trial $2M x x
UTMD Unlock Forecast - 30 Days FREE Trial $194M 15.5x 1.7x
VERO Unlock Forecast - 30 Days FREE Trial $4M 0.0x 1.8x
WST Unlock Forecast - 30 Days FREE Trial $20383M 44.4x 6.7x
XTNT Unlock Forecast - 30 Days FREE Trial $99M -478.8x 2.0x

Frequently Asked Questions - TriSalus Life Sciences, Inc. Stock Forecast

How accurate are TriSalus Life Sciences, Inc. stock predictions?

Our AI model shows a 27% Spearman correlation coefficient for TLSI predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence TriSalus Life Sciences, Inc. stock price forecasts?

Our analysis considers TriSalus Life Sciences, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is TriSalus Life Sciences, Inc. a good investment in 2025?

Based on our AI analysis, TriSalus Life Sciences, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are TriSalus Life Sciences, Inc. forecasts updated?

TriSalus Life Sciences, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced TriSalus Life Sciences, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for TriSalus Life Sciences, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...